MoneyWorks4Me

Supriya Lifescience - Quaterly Results

27 May 2025 Evaluate
The company witnessed a 16.39% growth in the revenue at Rs. 1841.09 millions for the quarter ended March 2025 as compared to Rs. 1581.80 millions during the year-ago period.Good  Net Profit growth of 36.42% reported above the corresponding previous quarter figure of Rs. 369.32 millions to Rs. 503.82 millioins.Operating Profit saw a handsome growth to 705.60 millions from 576.90 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1841.09 1581.80 16.39 6964.85 5703.40 22.12 6964.85 5703.40 22.12
Other Income 29.75 21.85 36.16 98.15 106.35 -7.71 98.15 106.35 -7.71
PBIDT 705.60 576.90 22.31 2706.11 1836.10 47.38 2706.11 1836.10 47.38
Interest 4.17 6.01 -30.62 16.86 21.10 -20.09 16.86 21.10 -20.09
PBDT 701.43 570.89 22.87 2689.25 1815.00 48.17 2689.25 1815.00 48.17
Depreciation 60.81 39.14 55.37 204.44 158.11 29.30 204.44 158.11 29.30
PBT 640.62 531.75 20.47 2484.81 1656.89 49.97 2484.81 1656.89 49.97
TAX 136.80 162.43 -15.78 605.23 465.76 29.94 605.23 465.76 29.94
Deferred Tax 9.08 72.99 -87.56 38.66 94.76 -59.20 38.66 94.76 -59.20
PAT 503.82 369.32 36.42 1879.58 1191.13 57.80 1879.58 1191.13 57.80
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 38.33 36.47 5.08 38.85 32.19 20.69 38.85 32.19 20.69
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..